| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 6824067 | Schizophrenia Research | 2015 | 5 Pages |
Abstract
The preliminary results suggest no differences in D2/3R availability between antipsychotic-free older patients with schizophrenia and controls.
Keywords
Related Topics
Life Sciences
Neuroscience
Behavioral Neuroscience
Authors
Shinichiro Nakajima, Fernando Caravaggio, David C. Mamo, Benoit H. Mulsant, Jun Ku Chung, Eric Plitman, Yusuke Iwata, Philip Gerretsen, Hiroyuki Uchida, Takefumi Suzuki, Wanna Mar, Alan A. Wilson, Sylvain Houle, Ariel Graff-Guerrero,
![First Page Preview: Dopamine D2/3 receptor availability in the striatum of antipsychotic-free older patients with schizophrenia-A [11C]-raclopride PET study Dopamine D2/3 receptor availability in the striatum of antipsychotic-free older patients with schizophrenia-A [11C]-raclopride PET study](/preview/png/6824067.png)